Clinical Trial Update: Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

View source ↗

Summary

A clinical trial update on an integrated genomics approach in oncogene-driven non-small cell lung cancer with acquired resistance, currently enrolling by invita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Oncogene-addicted Non Small Cell Lung Cancer, EGFR Mutation | Status: ENROLLING_BY_INVITATION